[Long-term treatment of essential hypertension using a beta-receptor blockader: effect on total-body-potassium and exchangeable sodium]. 1976

H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010869 Pindolol A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638) Prindolol,LB-46,Visken,LB 46,LB46
D011188 Potassium An element in the alkali group of metals with an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte that plays a significant role in the regulation of fluid volume and maintenance of the WATER-ELECTROLYTE BALANCE.
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012964 Sodium A member of the alkali group of metals. It has the atomic symbol Na, atomic number 11, and atomic weight 23. Sodium Ion Level,Sodium-23,Ion Level, Sodium,Level, Sodium Ion,Sodium 23
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
April 1979, Scandinavian journal of clinical and laboratory investigation,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
December 1981, Clinical science (London, England : 1979),
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
January 1976, Advances in clinical pharmacology,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
November 1968, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
September 1958, The Journal of clinical investigation,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
August 1976, Paraplegia,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
February 1972, British medical journal,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
February 1978, Clinical science and molecular medicine,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
October 1988, Clinical and experimental pharmacology & physiology,
H M Brecht, and E Werner, and J Vlachoyannis, and P B Bechstein, and W Schoeppe
May 1980, ZFA. Zeitschrift fur Allgemeinmedizin,
Copied contents to your clipboard!